Subscribe

Charlotte's Web Holdings, Inc. (CWBHF)

USD0.26 -0.01 (-5.19%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address 1801 California Street 80202
Louisville, CO, US
CEO Marcel Bonn-Miller
IPO 2018-09-12
CIK 1750155 ISIN CA16106R1091

Explore sections of this company profile

Also trades on Other OTC · CWBHF (USD) Toronto Stock Exchange · CWEB.TO (CAD)
Description

Charlotte's Web Holdings, Inc. specializes in the cultivation, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) wellness products. Their extensive product range includes liquid hemp extract tinctures, various gummies (designed for sleep, stress relief, immune support, and exercise recovery), capsules, topical CBD creams and lotions, and specific offerings for pets. These are sold under prominent brands such as Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids like CBD, cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), along with terpenes, flavonoids, and a spectrum of other beneficial hemp compounds. The company reaches its customers through multiple channels, including traditional retail outlets, health care practitioners, and direct-to-consumer sales via its official website. Charlotte's Web actively advances hemp cannabinoid science through key collaborations. Its CW Labs division works with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 and headquartered in Denver, Colorado, the company was formerly known as Stanley Brothers Holdings Inc. before officially changing its name to Charlotte's Web Holdings, Inc. in July 2018.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.26 -0.01 (-5.19%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
491.1K
Beta
2.20
Float Shares
111.14M
Free Float %
69.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.12% +5.65% -22.18% -36.88% +456.96% +32.53% +422.58% +54.29% -85.18% -96.24% -96.24%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (3 ratings, all time) Hold
Price Targets & DCF
Current price
0.26
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-6.20
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +0.5% Q1'26: -9.0% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    +0.0% Q1'26: -104.1% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -35.5% Q1'26: -25.1% (vs Q1'25)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -40.6% Q1'26: +0.0% (vs Q1'25)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -37.3% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +0.7% Q1'26: -100.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    -4.62× Q1'26: -0.09× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.24) × ERP
WACC = 54% × Ke + 46% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.26
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
69.50M
est: 69.95M (-0.6%)
94.59M
est: 98.44M (-3.9%)
95.23M
est: 95.80M (-0.6%)
96.09M
est: 98.87M (-2.8%)
74.14M
est: 76.14M (-2.6%)
63.16M
est: 69.99M (-9.8%)
49.67M
est: 49.83M (-0.3%)
49.90M
est: 48.90M (+2.0%)
54.70M
54.70M – 54.70M
+11.9% YoY
62.60M
62.60M – 62.60M
+14.4% YoY
69.20M
69.20M – 69.20M
+10.5% YoY
EBITDA
16.42M
est: -31.15M (+152.7%)
-16.82M
est: -43.84M (+61.6%)
-40.60M
est: -42.66M (+4.8%)
-38.03M
est: -44.03M (+13.6%)
-42.05M
est: -33.91M (-24.0%)
-24.90M
est: -31.17M (+20.1%)
-22.01M
est: -6.25M (-251.9%)
-13.95M
est: -6.14M (-127.2%)
-6.86M
-6.86M – -6.86M
-11.9% YoY
-7.86M
-7.86M – -7.86M
-14.4% YoY
-8.68M
-8.68M – -8.68M
-10.5% YoY
EBIT
14.99M
est: -41.59M (+136.0%)
-20.88M
est: -58.53M (+64.3%)
-51.34M
est: -56.97M (+9.9%)
-49.06M
est: -58.79M (+16.6%)
-50.65M
est: -45.28M (-11.9%)
-40.06M
est: -41.62M (+3.7%)
-31.99M
est: -28.68M (-11.5%)
-20.27M
est: -28.14M (+28.0%)
-31.48M
-31.48M – -31.48M
-11.9% YoY
-36.02M
-36.02M – -36.02M
-14.4% YoY
-39.82M
-39.82M – -39.82M
-10.5% YoY
Net Income
11.81M
est: 23.11M (-48.9%)
-15.57M
est: 4.01M (-488.2%)
-47.19M
est: -47.27M (+0.2%)
-137.72M
est: -30.20M (-356.0%)
-59.31M
est: -26.79M (-121.4%)
-23.80M
est: -24.42M (+2.6%)
-29.85M
est: -31.28M (+4.6%)
-29.74M
est: -23.79M (-25.0%)
-19.03M
-19.03M – -19.03M
+20.0% YoY
1.59M
1.59M – 1.59M
+108.3% YoY
4.76M
4.76M – 4.76M
+200.0% YoY
SGA
36.12M
est: 69.33M (-47.9%)
70.77M
est: 97.57M (-27.5%)
77.67M
est: 94.96M (-18.2%)
97.64M
est: 97.99M (-0.4%)
70.06M
est: 75.47M (-7.2%)
69.92M
est: 69.37M (+0.8%)
53.25M
est: 49.65M (+7.2%)
41.97M
est: 48.71M (-13.8%)
54.50M
54.50M – 54.50M
+11.9% YoY
62.37M
62.37M – 62.37M
+14.4% YoY
68.94M
68.94M – 68.94M
+10.5% YoY
EPS
0.12
est: 0.15 (-18.2%)
-0.16
est: 0.03 (-728.7%)
-0.38
est: -0.30 (-26.7%)
-0.98
est: -0.19 (-411.3%)
-0.40
est: -0.17 (-135.3%)
-0.16
est: -0.16 (-3.2%)
-0.19
est: -0.20 (+3.7%)
-0.19
est: -0.15 (-26.7%)
-0.12
-0.12 – -0.12
+20.0% YoY
0.01
0.01 – 0.01
+108.3% YoY
0.03
0.03 – 0.03
+200.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-12 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-11 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-08 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-07 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-06 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-05 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-04 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-01 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-30 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-29 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-28 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-27 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-24 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-14.49M
OE per share TTM
-0.09
Owner's Yield
-18.81%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
62.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1
Total invested
74.00
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 JESSE STANLEY 6.69M 4.40% 6.69M 6.69M 10.00 IN United States 2023-06-16
2 JOEL STANLEY 4.19M 2.70% 4.19M 4.19M 10.00 IN United States 2023-06-16
3 LYNN KEHLER 1.55M 1.00% 1.55M 1.55M 10.00 IN United States 2023-06-16

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
1
+0 vs prev Q
New positions
1
Closed positions
1
Increased
1
Reduced
0
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 MAIN STREET GROUP, LTD 100.00 +100.0 (+100.0%) 74.00 +74.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.73 +0.0% 6 qtrs
2 LEO H. EVART, INC. 3.00 +3.0 (+100.0%) 2.00 +2.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.67 +9.0% 1 qtrs NEW
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
8
Sells
8
Shares acquired
2.17M
Shares disposed
257.7K
Cash buys
Cash sales
Net activity
+1,910,382
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-04-06 Garrison Mindy Beth Officer Common Shares 0 0.00 211,934 D
2026-04-01 Stanley Jared Director F-InKind D Common Shares 12,659 0.78 9.9K 202,291 D
2026-04-01 Morachnick William J. Director / Officer A-Award A Restricted Stock Unit 1,178,647 0.00 1,178,647 D
2026-04-01 Lind Erika Officer M-Exempt D Restricted Stock Unit 26,562 0.00 26,562 D
2026-04-01 Kunkel Raymond J. Officer M-Exempt D Restricted Stock Unit 54,598 0.00 109,197 D
2026-03-31 Morachnick William J. Director / Officer M-Exempt A Common Shares 375,000 0.00 3,102,327 D
2025-12-31 Morachnick William J. Director / Officer M-Exempt A Common Shares 375,000 0.00 2,838,515 D
2025-11-01 Walker Margaret Borgia Director 0 0.00 0
2025-09-30 Morachnick William J. Director / Officer M-Exempt A Common Shares 375,000 0.00 2,554,828 D
2025-09-02 Kunkel Raymond J. Officer P-Purchase A Common Shares 229,167 0.10 22.9K 718,922 D
2025-07-01 Usifer Maureen K Director A-Award A Restricted Stock Unit 75,000 0.00 75,000 D
2025-07-01 McElwee Angela May Director M-Exempt D Restricted Stock Unit 85,000 0.00 0 D
2025-07-01 McCarthy Matthew Evan Director A-Award A Restricted Stock Unit 75,000 0.00 75,000 D
2025-06-30 Morachnick William J. Director / Officer M-Exempt A Common Shares 375,000 0.00 2,271,141 D
2025-05-30 Kunkel Raymond J. Officer P-Purchase A Common Shares 5,000 0.10 515.00 481,065 D
2025-04-01 Stanley Jared Director M-Exempt D Restricted Stock Unit 37,177 0.00 74,356 D
2025-04-01 Rogers Stephen David Officer A-Award A Restricted Stock Unit 147,285 0.00 147,285 D
2025-04-01 Lind Erika Officer M-Exempt D Restricted Stock Unit 26,562 0.00 53,124 D
2025-04-01 Kunkel Raymond J. Officer M-Exempt D Restricted Stock Unit 34,318 0.00 68,636 D
2025-03-31 Morachnick William J. Director / Officer F-InKind D Common Shares 2 0.09 0.18 1,896,141 D
2024-12-31 Morachnick William J. Director / Officer M-Exempt D Restricted Stock Unit 375,000 0.00 2,625,000 D
2024-09-30 Morachnick William J. Director / Officer M-Exempt A Common Shares 375,000 0.00 1,489,457 D
2024-09-03 Kunkel Raymond J. Officer P-Purchase A Common Shares 125,167 0.15 18.8K 239,845
2024-08-30 Kunkel Raymond J. Officer P-Purchase A Common Shares 2,479 0.14 354.50 114,678
2024-08-29 Kunkel Raymond J. Officer P-Purchase A Common Shares 8,100 0.14 1.2K 112,199
2024-08-28 Kunkel Raymond J. Officer P-Purchase A Common Shares 10,000 0.14 1.4K 104,099
2024-08-27 Kunkel Raymond J. Officer P-Purchase A Common Shares 2,000 0.14 280.00 94,099
2024-07-02 Morga Alicia Director S-Sale D Charlottes Web Holding Inc common stock 510,134 0.16 79.2K 0
2024-07-01 Usifer Maureen K Director A-Award A Restricted Stock Unit 75,000 0.00 75,000
2024-07-01 McElwee Angela May Director A-Award A Restricted Stock Unit 85,000 0.00 85,000
2024-07-01 McCarthy Matthew Evan Director A-Award A Restricted Stock Unit 75,000 0.00 75,000
2024-06-30 Morachnick William J. Director / Officer M-Exempt D Restricted Stock Unit 375,000 0.00 3,375,000
2024-06-29 Lind Erika Officer D Common Shares 0 0.00 7,661
2024-06-13 Usifer Maureen K Director 0 0.00 0
2024-04-01 Stanley Jared Officer A-Award A Restricted Stock Unit 111,533 0.00 111,533
2024-04-01 Saxton Jessica Officer A-Award A Restricted Stock Unit 710,000 0.00 710,000
2024-04-01 Rogers Stephen David Officer A-Award A Restricted Stock Unit 105,013 0.00 105,013
2024-04-01 Lind Erika Officer D Stock Option (right to buy) 34,891 0.32 11.2K 0
2024-04-01 Kunkel Raymond J. Officer A-Award A Restricted Stock Unit 102,954 0.00 102,954
2024-04-01 Garrison Mindy Beth Officer Stock Option (right to buy) 51,245 0.32 16.4K 0 D
2024-04-01 Cambridge Sarah Officer A-Award A Restricted Stock Unit 75,843 0.00 75,843
2024-03-31 Morachnick William J. Director / Officer F-InKind D Common Shares 107,813 0.20 21.6K 847,270
2024-02-06 McCarthy Matthew Evan Director 0 0.00 0
2024-02-01 VOGT SUSAN L N Director M-Exempt A Common Shares 441,176 0.00 644,061
2024-02-01 Stanley Jared Officer M-Exempt A Common Shares 37,500 0.00 155,958
2024-02-01 Saxton Jessica Officer M-Exempt A Common Shares 312,500 0.00 491,071
2024-02-01 Rogers Stephen David Officer M-Exempt D Restricted Stock Unit 21,806 0.00 0
2024-02-01 Morga Alicia Director M-Exempt A Common Shares 441,176 0.00 510,134
2024-02-01 LARDIERI THOMAS M Director M-Exempt A Common Shares 441,176 0.00 553,127
2024-02-01 Kunkel Raymond J. Officer F-InKind D Common Shares 11,612 0.18 2.1K 92,099
2024-02-01 HELD JOHN D Director M-Exempt A Common Shares 500,000 0.00 749,274
2024-02-01 Cambridge Sarah Officer M-Exempt A Common Shares 13,811 0.00 13,811
2023-12-31 Morachnick William J. Director / Officer M-Exempt D Restricted Stock Unit 375,000 0.00 4,125,000
2023-12-22 Kunkel Raymond J. Officer M-Exempt D Restricted Stock Unit 39,216 0.00 0
2023-12-06 Morga Alicia Director M-Exempt A Common Shares 68,958 0.00 68,958
2023-11-19 Rogers Stephen David Officer M-Exempt A Common Shares 16,556 0.20 3.4K 55,516
2023-11-19 Kunkel Raymond J. Officer M-Exempt A Common Shares 23,179 0.20 4.7K 48,310
2023-10-12 Morachnick William J. Director / Officer A-Award A Restricted Stock Unit 4,500,000 0.00 4,500,000
2023-10-11 McElwee Angela May Director 0 0.00 0
2023-10-09 Kunkel Raymond J. Officer D Common Shares 0 0.00 25,131
2023-09-13 TORTOROLI JACQUES Director / Officer M-Exempt A Common Shares 65,000 0.36 23.1K 1,010,356 D
2023-09-13 Morachnick William J. Director / Officer A-Award A Common Shares 500,000 0.36 177.5K 500,000
2023-08-28 Cambridge Sarah Officer D Restricted Stock Unit 13,811 0.00 0
2023-08-10 LARDIERI THOMAS M Director M-Exempt A Common Shares 111,951 0.28 31.6K 111,951
2023-08-08 Garrison Mindy Beth Officer Stock Option (right to buy) 166,667 0.60 100.0K 0 D
2023-07-01 VOGT SUSAN L N Director A-Award A Restricted Stock Unit 441,176 0.00 441,176
2023-07-01 Morga Alicia Director A-Award A Restricted Stock Unit 441,176 0.00 441,176
2023-07-01 LARDIERI THOMAS M Director A-Award A Restricted Stock Unit 441,176 0.00 441,176
2023-07-01 HELD JOHN D Director A-Award A Restricted Stock Unit 500,000 0.00 500,000
2023-06-22 VOGT SUSAN L N Director M-Exempt D Restricted Stock Unit 163,043 0.00 0
2023-06-22 HELD JOHN D Director M-Exempt A Common Shares 184,782 0.18 32.6K 249,274
2023-04-01 TORTOROLI JACQUES Director / Officer A-Award A Restricted Stock Unit 25,441 0.00 25,441
2023-04-01 Stanley Jared Officer A-Award A Restricted Stock Unit 23,624 0.00 23,624
2023-04-01 Saxton Jessica Officer A-Award A Restricted Stock Unit 312,500 0.00 312,500
2023-04-01 Rogers Stephen David Officer A-Award A Stock Option (right to buy) 65,420 0.32 20.9K 65,420
2023-03-26 Stanley Jared Officer M-Exempt A Common Shares 6,483 0.31 2.0K 105,596
2023-03-14 Atwood Jonathan Phelps Director 0 0.00 0
2023-02-11 TORTOROLI JACQUES Director / Officer M-Exempt A Common Shares 32,500 0.50 16.3K 529,700
2023-02-11 Stanley Jared Officer M-Exempt D Restricted Stock Unit 18,750 0.00 37,500
2023-02-11 Rogers Stephen David Officer M-Exempt D Restricted Stock Unit 12,500 0.00 25,000
2023-02-11 Kunkel Raymond J. Officer D Stock Option (right to buy) 52,500 1.56 81.9K 0
2023-02-11 Garrison Mindy Beth Officer Stock Option (right to buy) 37,500 1.56 58.5K 0 D
2023-02-01 Saxton Jessica Officer A-Award A Stock Option (right to buy) 535,714 0.56 300.0K 535,714
2023-01-01 Saxton Jessica 0
2022-12-31 TORTOROLI JACQUES Officer M-Exempt A Common Shares 425,000 0.52 220.3K 635,078
2022-12-16 TORTOROLI JACQUES Officer M-Exempt A Common Shares 62,500 0.60 37.5K 228,140
2022-12-06 Morga Alicia 0
2022-12-06 Birch Jean Director M-Exempt A Common Shares 163,043 0.63 102.0K 210,385
2022-11-19 Rogers Stephen David Officer M-Exempt A Common Shares 16,556 0.60 10.0K 35,502
2022-11-14 BT DE Investments Inc. Director D Convertible Debenture 37,670,540 0.00
2022-08-10 LARDIERI THOMAS M Director A-Award A Restricted Stock Unit 111,951 0.00 111,951
2022-08-02 TORTOROLI JACQUES Officer A-Award A Restricted Stock Unit 850,000 0.00 850,000
2022-08-02 Stanley Jared Officer D Stock Option (right to buy) 35,386 4.70 166.3K 0
2022-07-01 Stanley Jared Officer F-InKind D Common Shares 7,369 0.47 3.5K 81,296
2022-07-01 Rogers Stephen David Officer M-Exempt D Restricted Stock Unit 26,315 0.00 0
2022-07-01 Jensen Lindsey Officer F-InKind D Common Shares 2,713 0.47 1.3K 29,034
2022-06-22 VOGT SUSAN L N Director A-Award A Restricted Stock Unit 163,043 0.46 75.0K 163,043
2022-06-22 Saunders Timothy Director A-Award A Restricted Stock Unit 163,043 0.46 75.0K 163,043
2022-06-22 HELD JOHN D Director A-Award A Restricted Stock Unit 184,782 0.46 85.0K 184,782
2022-06-22 Birch Jean Director A-Award A Restricted Stock Unit 163,043 0.46 75.0K 163,043
2022-06-20 Gould Gregory A Officer D No securities are beneficially owned 0 0.00 0
2022-06-18 Saunders Timothy Director M-Exempt D Restricted Stock Unit 18,380 0.00 0
2022-06-17 Gould Gregory A Officer A-Award A Stock Option (right to buy) 1,200,000 0.44 528.0K 1,200,000
2022-06-16 TORTOROLI JACQUES Director / Officer F-InKind D Common Shares 18,063 0.43 7.8K 121,204
2022-06-09 VOGT SUSAN L N Director M-Exempt D Restricted Stock Unit 16,164 0.00 0
2022-06-09 TORTOROLI JACQUES Officer M-Exempt D Restricted Stock Unit 16,164 0.00 0
2022-06-09 HELD JOHN D Director M-Exempt D Restricted Stock Unit 18,319 0.00 0
2022-06-09 Birch Jean Director M-Exempt A Common Shares 16,164 0.52 8.4K 47,342
2022-05-01 Jensen Lindsey Officer A-Award A Stock Option (right to buy) 116,250 0.00 116,250
2022-03-26 Stanley Jared Officer M-Exempt A Common Shares 6,483 1.24 8.0K 62,471
2022-03-26 Kunkel Raymond J. Officer D Stock Option (right to buy) 6,532 4.70 30.7K 0
2022-03-16 TORTOROLI JACQUES Officer M-Exempt D Restricted Share Award 62,500 0.00 187,500
2022-02-22 Stanley Jared Officer A-Award A Restricted Stock Unit 26,315 0.00 26,315
2022-02-22 Rogers Stephen David Officer A-Award A Restricted Stock Unit 26,315 0.00 26,315
2022-02-22 De Gortari Andy Officer A-Award A Restricted Stock Unit 26,315 0.00 26,315
2022-02-22 Booysen Wessel Officer A-Award A Restricted Stock Unit 43,859 0.00 43,859
2022-02-11 TORTOROLI JACQUES Director / Officer A-Award A Restricted Share Award 97,500 0.00 97,500
2022-02-11 Stanley Jared Officer A-Award A Restricted Share Award 56,250 0.00 56,250
2022-02-11 Rogers Stephen David Officer A-Award A Restricted Share Award 37,500 0.00 37,500
2022-02-11 De Gortari Andy Officer A-Award A Restricted Share Award 43,750 0.00 43,750
2022-02-11 Booysen Wessel Officer A-Award A Stock Option (right to buy) 270,000 1.56 421.2K 270,000
2022-01-09 Stanley Jared Officer J-Other D Common Shares 2,075,798 0.00 0
2022-01-04 VOGT SUSAN L N Director D Restricted Share Award 16,164 0.00 0
2022-01-04 True William Anthony Officer D Stock Option (right to buy) 41,918 4.70 197.0K 0
2022-01-04 TORTOROLI JACQUES Director / Officer D Stock Option (right to buy) 375,000 1.02 382.5K 0
2022-01-04 Saunders Timothy Director D Restricted Share Award 18,380 0.00 0
2022-01-04 Rogers Stephen David Officer D Restricted Share Award 49,669 0.00 0
2022-01-04 HELD JOHN D Director D Stock Option (right to buy) 11,100 5.37 59.6K 0
2022-01-04 De Gortari Andy Officer D Stock Option (right to buy) 9,739 3.57 34.8K 0
2022-01-04 Booysen Wessel Officer D Stock Option (right to buy) 86,291 4.35 375.4K 0
2022-01-04 Birch Jean Director D Stock Option (right to buy) 3,589 3.79 13.6K 0

Executive team

Top executives
EBIT / Employee
-181.0K
Shares Outstanding
160.54M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 William Morachnick Chief Executive Officer 567.3K 45.0K 27.9K 640.2K 0.00%
2 2025 Raymond Kunkel Chief Operating Officer 361.5K 172.5K 14.7K 10.9K 559.7K 2.63%
3 2025 Erika Lind Chief Financial Officer 299.4K 119.0K 12.2K 12.5K 443.1K 2.74%
4 2025 Stephen Rogers Former Senior Vice President – General Counsel 205.4K 18.3K 13.3K 154.5K 391.5K 3.39%
5 2024 William Morachnick Chief Executive Officer 450.0K 150.5K 75.1K 675.6K 0.00%
6 2024 Jessica Saxton Former Chief Financial Officer 164.6K 332.5K 149.1K 27.7K 673.8K 22.13%
7 2024 Raymond Kunkel Chief Operating Officer 300.0K 55.1K 21.6K 12.8K 389.5K 5.55%
8 2024 Stephen Rogers Former Senior Vice President – General Counsel 304.8K 27.0K 22.1K 26.7K 380.5K 5.80%
9 2024 Stephen Rogers Senior Vice President – General Counsel 304.8K 27.0K 22.1K 26.7K 380.5K 5.80%
10 2024 Jared Stanley Former Chief Commercialization Officer 161.3K 46.1K 23.4K 12.0K 242.8K 9.65%
11 2023 William Morachnick Chief Executive Officer 117.7K 1.48M 13.3K 1.61M 91.87%
12 2023 Jessica Saxton Former Chief Financial Officer 288.5K 200.0K 455.4K 46.0K 989.8K 66.21%
13 2023 Jessica Saxton Chief Financial Officer 288.5K 200.0K 455.4K 46.0K 989.8K 66.21%
14 2023 Jared Stanley Chief Commercialization Officer 325.0K 7.6K 17.6K 20.7K 370.8K 6.78%
15 2023 Jared Stanley Former Chief Commercialization Officer 325.0K 7.6K 17.6K 20.7K 370.8K 6.78%
16 2023 Jacques Tortoroli Former Chief Executive Officer 259.8K 8.1K 18.9K 55.9K 342.8K 7.90%
17 2022 Jacques Tortoroli Former Chief Executive Officer 399.7K 738.6K 324.1K 67.4K 1.53M 69.47%
18 2022 Jacques Tortoroli Chief Executive Officer 399.7K 738.6K 324.1K 67.4K 1.53M 69.47%
19 2022 Wessel Booysen Former Chief Financial and Operating Officer 187.3K 190.4K 299.2K 258.6K 935.5K 52.33%
20 2022 Gregory Gould Former Chief Financial Officer 162.5K 100.0K 378.0K 100.0K 7.4K 747.9K 50.54%
21 2022 Jared Stanley Chief Operating Officer 325.0K 117.7K 187.0K 17.6K 647.4K 47.07%
22 2022 Jared Stanley Chief Commercialization Officer 325.0K 117.7K 187.0K 17.6K 647.4K 47.07%
23 2022 Stephen Rogers SVP, General Counsel and Corporate Secretary 300.0K 88.5K 124.7K 42.5K 555.7K 38.36%
24 2021 Adrienne Elsner Former Chief Executive Officer 649.0K 625.0K 625.0K 17.0K 1.92M 65.24%
25 2021 Russell Hammer Former Chief Financial Officer 349.8K 267.5K 267.5K 997.8K 1.88M 28.42%
26 2021 Wessel Booysen Chief Financial and Operating Officer 277.8K 549.5K 267.5K 11.1K 1.11M 73.88%
27 2021 Wessel Booysen Former Chief Financial and Operating Officer 277.8K 549.5K 267.5K 11.1K 1.11M 73.88%
28 2021 W. Anthony True Chief Customer Officer 385.0K 294.4K 144.4K 20.6K 844.4K 51.96%
29 2021 Jacques Tortoroli Chief Executive Officer 19.6K 330.0K 256.9K 92.1K 679.0K 86.44%
30 2020 Adrienne Elsner Former Chief Executive Officer 625.0K 100.00 390.7K 1.17M 455.0K 21.9K 2.66M 58.59%
31 2020 Russell Hammer Former Chief Financial Officer 535.0K 100.00 200.7K 600.2K 276.0K 16.6K 1.63M 49.17%
32 2020 W. Anthony True Chief Customer Officer 385.0K 100.00 72.2K 216.0K 143.0K 26.9K 843.2K 34.18%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2026-04-06 PRE 14A
2026-04-01 DEFA14A
2026-03-31 DEFA14A
2026-03-31 DEFA14A
2025-04-29 DEFA14A
2025-04-29 DEF 14A
2024-04-29 DEFA14A
2024-04-29 DEFA14A
2024-04-29 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-13 8-K
2026-05-13 10-Q
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2026-04-16 ARS
2026-04-14 3
2026-04-06 PRE 14A
2026-04-03 4
2026-04-03 4
2026-04-03 4

Executive team

NameTitleCompensationGender
William J. Morachnick Chief Executive Officer & Non-Independent Director 640.2K male
Raymond Kunkel Chief Operating Officer 545.0K male
Erika Lind Chief Financial Officer & Principal Accounting Officer 430.9K female
Gregory A. Gould Chief Administration Officer 369.9K male
Jared Stanley Co-Founder & Director 138.5K male
Kelly Shea Senior Vice President of Government Affairs & Corporate Communications female
Cory Pala Director of Investor Relations male
Marcel Bonn-Miller Chief Scientific Officer
Mindy Garrison Chief People Officer & Corporate Secretary female
ESG Rating
B
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Rank: 47 out of 119
2026
E (Environmental)
65.5 / 66.0
Company / Sector avg.
S (Social)
62.9 / 70.0
Company / Sector avg.
G (Governance)
67.6 / 66.6
Company / Sector avg.
ESG Total
65.4 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits